Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Fluorescent Imaging during Surgery to Identify Tissue Blood Flow and Decrease Pharyngocutaneous Fistula Rates in Laryngeal and Hypopharyngeal Cancer Patients Undergoing Total Laryngectomy

Trial Status: active

This phase II trial studies whether fluorescent imaging during surgery (intraoperative) can be used to identify tissue blood flow and decrease pharyngocutaneous fistula rates in patients with laryngeal and hypopharyngeal squamous cell carcinoma who are undergoing surgery to completely remove the voicebox (total laryngectomy). With any surgery, there is always a possibility of complications. One complication after total laryngectomy is called a pharyngocutaneous fistula (PF). A PF is a leak in the pharynx (the tube that helps people breathe and digest food). PFs are more likely to develop when the tissue has decreased blood flow. The fluorescent imaging used in this study is the SPY trademark Elite Fluorescence imaging system. The SPY Elite Fluorescence imaging system uses a dye called indocyanine green to allow surgeons to visualize microvascular blood flow and perfusion in tissue intraoperatively. This may help surgeons better see tissue with decreased blood flow and allow them to remove it during surgery, which may decrease PF rates.